BetterScholar BetterScholar

M. Turner

Journal for ImmunoTherapy of Cancer, Journal of Immunotherapy for Cancer, Advances in Radiation Oncology, The Oncologist, Gastroenterology, Supportive Care in Cancer, Current Oncology, Journal of Thoracic Oncology Show more
11
Role
Title
Level Year L/R
🐜 Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
81 auth. I. Puzanov, A. Diab, K. Abdallah, C. Bingham, C. Brogdon, R. Dadu, L. Hamad, S. Kim, M. Lacouture, N. LeBoeuf, D. Lenihan, C. Onofrei, V. Shannon, R. Sharma, A. Silk, ... D. Skondra, M. Suarez‐Almazor, Y. Wang, K. Wiley, H. Kaufman, M. Ernstoff, J. Anderson, Deborah Arrindell, S. Andrews, J. Ballesteros, J. Boyer, Daniel S Chen, David Chonzi, I. Cotarla, R. Cunha, M. Davies, M. Dawson, A. Dicker, L. Eifler, Andrew D. Ferguson, C. Ferlini, S. Frankel, W. Go, Celestine G. Gochett, J. Goldberg, P. Goncalves, T. Goswami, Nancy C. Gregory, J. Gulley, V. Hayreh, Nicole Helie, William C. Holmes, J. hsu, R. Ibrahim, C. Larocca, K. Lehman, S. Ley-Acosta, O. Lambotte, J. Luke, J. Mcclure, E. Michelon, Mary C. Nakamura, K. Patel, B. Piperdi, Z. Rasheed, D. Reshef, J. Riemer, C. Robert, M. Sarkeshik, Ann Saylors, J. Schreiber, K. Shafer-Weaver, W. Sharfman, E. Sharon, R. Sherry, C. Simonson, C. Thomas, John A Thompson, E. Trehu, D. Tresnan, M. Turner, Darshan Wariabharaj, I. Waxman, L. Wood, Lin Zhang, P. Zheng 		10 2017
10
🐜
🐜 Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
23 auth. J. Brahmer, Hamzah Abu-Sbeih, P. Ascierto, J. Brufsky, L. Cappelli, Frank B. Cortazar, D. Gerber, L. Hamad, Eric D. Hansen, Douglas B. Johnson, ... M. Lacouture, G. Masters, J. Naidoo, M. Nanni, M. Perales, I. Puzanov, B. Santomasso, S. Shanbhag, Rajeev Sharma, D. Skondra, J. Sosman, M. Turner, M. Ernstoff 		8 2021
8
🐜
🐜 Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
18 auth. J. Naidoo, C. Murphy, M. Atkins, J. Brahmer, S. Champiat, D. Feltquate, L. Krug, J. Moslehi, M. Pietanza, J. Riemer, ... C. Robert, E. Sharon, M. Suarez‐Almazor, K. Suresh, M. Turner, J. Weber, L. Cappelli, Twitter Jarushka 		6 2023
6
🐜
🐜 Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (β‰₯60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
16 auth. M. Vyfhuis, N. Bhooshan, W. Burrows, M. Turner, M. Suntharalingam, James M. Donahue, E. Nichols, J. Feliciano, S. Bentzen, S. Badiyan, ... Shamus R. Carr, J. Friedberg, C. Simone, M. Edelman, S. Feigenberg, P. Mohindra 		4 2017
4
🐜
🐜 Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy
19 auth. M. Hsu, J. Murray, K. Psoter, Jiajia Zhang, D. Barasa, J. Brahmer, D. Ettinger, P. Forde, C. Hann, V. Lam, ... B. Levy, K. Marrone, Tricia Patel, V. Peterson, Sarah Sagorsky, M. Turner, V. Anagnostou, J. Naidoo, J. Feliciano 		3 2022
3
🐜
🐜 Accurate Non-Endoscopic Detection of Esophageal Squamous Cell Carcinoma (ESCC) Using Methylated DNA Biomarkers.
29 auth. Ke Ma, Andrew Kalra, H. Tsai, S. Okello, Yulan Cheng, S. Meltzer, B. Lumori, C. Opio, S. Jit, Ludmila V. Danilova, Zhe Wang, C. Şimşek, S. Ngamruengphong, E. Shin, M. Khashab, ... Vikesh K. Singh, Alan H. Tieu, Corey M. Nolet, Dennis Gong, K. Chang, V. Prasath, R. Bollinger, Tza-Huei Wang, J. Feliciano, V. Lam, R. Battafarano, M. Turner, Peggy Lang, K. Marrone 		3 2022
3
🐜
🐜 Lung cancer and family-centered concerns
13 auth. J. Feliciano, Alexander Chang, D. Venkatraman, Samara Brooks, Ciara Zagaja, D. Ettinger, C. Hann, J. Naidoo, R. Voong, R. Hales, ... M. Turner, V. Peterson, J. Bodurtha 		2 2019
2
🐜
🐜 An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis
18 auth. K. Liang, S. Tackett, Samantha Myers, J. Brahmer, I. Browner, David S. Ettinger, P. Forde, R. Hales, C. Hann, V. Lam, ... K. Marrone, Tricia Patel, V. Peterson, Sarah Sagorsky, M. Turner, K. R. Voong, J. Naidoo, J. Feliciano 		1 2022
1
🐜
🐜 Immune checkpoint inhibition in elderly non-small cell lung cancer patients.
15 auth. K. Marrone, Jiajia Zhang, J. Feliciano, P. Forde, C. Hann, R. Kelly, D. Ettinger, M. Turner, V. Rowe, Sarah Bonerigo, ... Kellie N. Smith, V. Anagnostou, V. Velculescu, J. Brahmer, J. Naidoo 		0 2018
0
🐜
🐜 MA07.05 Survivors from Anti-PD-(L)1 Immunotherapy in NSCLC: Clinical Features, Survival Outcomes and Long-term Toxicities
14 auth. M. Hsu, J. Murray, J. Zhang, D. Barasa, M. Turner, P. Forde, D. Ettinger, V. Lam, K. Marrone, B. Levy, ... C. Hann, J. Brahmer, J. Feliciano, J. Naidoo 		0 2021
0
🐜
🦁 NU04.01 Management of Toxicities Associated with Immunotherapy in the Lung Cancer Patients
M. Turner 		0 2017
0
🦁